Portola Pharmaceuticals misses by $0.76, misses on revenue

Portola Pharmaceuticals (PTLA): Q2 EPS of -$1.47 misses by $0.76.

Revenue of $2.6M misses by $0.5M. (PR)

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs